These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16105658

  • 1. Vascular endothelial growth factor receptors in osteoclast differentiation and function.
    Aldridge SE, Lennard TW, Williams JR, Birch MA.
    Biochem Biophys Res Commun; 2005 Sep 30; 335(3):793-8. PubMed ID: 16105658
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ, Athanasou NA.
    J Pathol; 2008 May 30; 215(1):56-66. PubMed ID: 18283716
    [Abstract] [Full Text] [Related]

  • 3. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin.
    Yang Q, McHugh KP, Patntirapong S, Gu X, Wunderlich L, Hauschka PV.
    Matrix Biol; 2008 Sep 30; 27(7):589-99. PubMed ID: 18640270
    [Abstract] [Full Text] [Related]

  • 4. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
    Shibata H, Abe M, Hiura K, Wilde J, Moriyama K, Sano T, Kitazoe K, Hashimoto T, Ozaki S, Wakatsuki S, Kido S, Inoue D, Matsumoto T.
    Clin Cancer Res; 2005 Sep 01; 11(17):6109-15. PubMed ID: 16144909
    [Abstract] [Full Text] [Related]

  • 5. Osteoclast culture and resorption assays.
    Bradley EW, Oursler MJ.
    Methods Mol Biol; 2008 Sep 01; 455():19-35. PubMed ID: 18463808
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88.
    Yang J, Ryu YH, Yun CH, Han SH.
    J Leukoc Biol; 2009 Oct 01; 86(4):823-31. PubMed ID: 19602669
    [Abstract] [Full Text] [Related]

  • 12. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
    Chang EJ, Kim HJ, Ha J, Kim HJ, Ryu J, Park KH, Kim UH, Lee ZH, Kim HM, Fisher DE, Kim HH.
    J Cell Sci; 2007 Jan 01; 120(Pt 1):166-76. PubMed ID: 17164294
    [Abstract] [Full Text] [Related]

  • 13. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
    Hase H, Kanno Y, Kojima H, Sakurai D, Kobata T.
    Arthritis Rheum; 2008 Nov 01; 58(11):3356-65. PubMed ID: 18975335
    [Abstract] [Full Text] [Related]

  • 14. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
    Yen ML, Tsai HF, Wu YY, Hwa HL, Lee BH, Hsu PN.
    Mol Immunol; 2008 Apr 01; 45(8):2205-13. PubMed ID: 18206242
    [Abstract] [Full Text] [Related]

  • 15. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE, Wordsworth PB, Edwards JR, Ferguson DJ, Athanasou NA.
    Hum Pathol; 2006 Sep 01; 37(9):1176-85. PubMed ID: 16938523
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY, Yang D, Chang EJ, Lee Y, Huang H, Sung SH, Lee ZH, Kim YC, Kim HH.
    Biochem Pharmacol; 2007 Sep 15; 74(6):911-23. PubMed ID: 17662251
    [Abstract] [Full Text] [Related]

  • 17. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P.
    J Bone Miner Res; 2006 Feb 15; 21(2):193-206. PubMed ID: 16418775
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
    Mohamedali KA, Poblenz AT, Sikes CR, Navone NM, Thorpe PE, Darnay BG, Rosenblum MG.
    Cancer Res; 2006 Nov 15; 66(22):10919-28. PubMed ID: 17108129
    [Abstract] [Full Text] [Related]

  • 19. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
    Takahashi N.
    Clin Calcium; 2006 Jun 15; 16(6):940-47. PubMed ID: 16751689
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.